Dear Allstat;
Here is the latest vacancy for you to review.
* Location: Switzerland, Basel
* Salary: £40000 - £55 000
* My client will also provide you with £1000 for relocation, will help
you with finding accommodation.
* Bonus Scheme is included.
Position
Essential:Educated to Msc level in statistic or related subject, Minimum of
4-5 years of experience as a biostatistician within the pharmaceutical or
CRO industry on phase II and III Ideally in regulatory studies.
Desirable: SAS knowledge and experience of EMEA, FDA or MHRA meetings.
You will be working in a team of 6 biostatisticians and SAS programmers.
Working for this major client, you will be working on their Oncology and
Cardiovascular studies. SAS base, SAS macro, SAS stat, study design, study
analysis and participating in regulatory meetings with clients.
Tina Fakharan
Recruitment consultant
Pharmaceutical, Healthcare & CRO division.
1st IT People
Tel: +44 (0) 207 940 3900
Fax: +44 (0) 207 886 8161
mailto:[log in to unmask]
<mailto:[log in to unmask]>
www.1st-itpeople.com
Offices in UK, Switzerland, The Netherlands & Hong Kong
This email is confidential and intended solely for the use of the individual
to whom it is addressed. Any views or opinions presented are solely those of
the author and do not represent those of the company from which the email
was sent. If you are not the intended recipient, be advised that you have
received this e-mail in error and that any use, dissemination forwarding,
printing or copying of this e-mail is strictly prohibited. While every
effort has been made to scan this e-mail, we can not accept any
responsibility for loss of business or damage caused arising from this
e-mail.
This email is confidential and intended solely for the use of the
individual to whom it is addressed. Any views or opinions presented are
solely those of the author and do not represent those of the company from
which the email was sent. If you are not the intended recipient, be advised
that you have received this e-mail in error and that any use, dissemination
forwarding, printing or copying of this e-mail is strictly prohibited.
While every effort has been made to scan this e-mail, we can not accept any
responsibility for loss of business or damage caused arising from this
e-mail.
|